SPARC reports net loss of Rs 17.90 crore for Q3

02 Feb 2012 Evaluate

Sun Pharma Advanced Research Company (SPARC) has suffered a net loss of Rs 17.90 crore in the quarter ended December 31, 2011. The company had reported a net loss of Rs 2.94 crore for the third quarter last fiscal.

Total income of the company stood at Rs 4.51 crore in the quarter ended December 31, 2011. It was Rs 12.17 crore in the corresponding period last fiscal, down by 62.94%.

SPARC was demerged from Sun Pharma as a pharma research and drug discovery company in 2007.

Sun Pharma Adv. Res Share Price

152.85 0.90 (0.59%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 639.00
Indegene 534.25
CMS Info Systems 348.55
Sagility 49.32
Smartworks Coworking 446.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×